(Reuters) – Eli Lilly and Co and partner Incyte Corp on Tuesday said additional results from a late-stage study showed that their COVID-19 drug baricitinib reduced the risk of death in patients on mechanical ventilation.
(Reporting by Manojna Maddipatla in Bengaluru)
